Cosmetic ingredients and finished products are reaching more territories globally, but a shift is now happening towards advanced effective cosmetics. This requires complex testing without animals and in an ethical way. Prof Colin McGuckin is training the next generation of skin researchers – which has included two IFSCC Henry Maso award winners – to create artificial 3D bioprinted complex skin. This has included normal and abnormal skin, but also the world’s thickest lab-grown skin. In this webinar he will reveal what is now possible to prove that cosmetics really work.

REGISTER HERE

TIMES
Wednesday 15 January
8h West Coast USA • 10h Mexico City • Chicago • 11h East Coast USA / Bogotá • 13h Sao Paolo • 16h London • 17h Central Europe / West Africa • 18h Tel Aviv / South Africa • 9h30 New Delhi • 0h Singapore / HK / China / Taipei

Thursday 16 January
1h Korea / Japan • 3h Melbourne • 5h Wellington

BIOGRAPHY
After early research on leukaemia, chronic anaemia’s and stem cell disorders Prof Colin McGuckin developed a programme using human tissues for research and therapeutics, which also involved biobanking. His group was first in the world to characterise and produce embryonic-like stem cells from a non-embryonic source – umbilical cord blood (McGuckin et al, Cell Proliferation, 38, 245-255, 2005) and first to make an artificial liver, nervous, pancreatic and a range of other tissues from umbilical cord, cord blood and adipose related stem cells. He became the UK’s first Full Professor of Regenerative Medicine (Newcastle University, 2005), leading clinical research in adult stem cells through to patients. He strongly believes in international industry-academic cooperation. In 2009 he became President and CSO of CTIBIOTECH in France creating ‘close-to-patient’ human tissue models with advanced technologies like 3D Bioprinting, allowing for the next generation of personalised medicine. He has advanced global 3D Bioprinting to create the world’s most sophisticated skin models for drugs, vaccines, cosmetics and personal care testing, but these are also advancing to help burn’s patients and those with infections. His team won the 2022 Henry Maso Award for advanced cosmetics research and were runners up in the globally recognized Galien Prize 2022. In 2023, they won the global L’Oréal ‘Big Bang Innovation Prize’ for ground-breaking skin research.